X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (381) 381
Patent (92) 92
Publication (21) 21
Book Review (5) 5
Newspaper Article (5) 5
Book / eBook (2) 2
Dissertation (2) 2
Book Chapter (1) 1
Conference Proceeding (1) 1
Video Recording (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (211) 211
male (176) 176
middle aged (161) 161
female (133) 133
risk factors (124) 124
aged (112) 112
hygiene (82) 82
human necessities (81) 81
medical or veterinary science (81) 81
preparations for medical, dental, or toilet purposes (81) 81
specific therapeutic activity of chemical compounds ormedicinal preparations (80) 80
cardiac & cardiovascular systems (79) 79
cardiovascular disease (73) 73
adult (72) 72
chemistry (71) 71
heterocyclic compounds (71) 71
metallurgy (71) 71
organic chemistry (71) 71
medicine, general & internal (54) 54
mortality (54) 54
abridged index medicus (47) 47
prospective studies (45) 45
cardiovascular diseases (42) 42
follow-up studies (37) 37
prevention (37) 37
risk (36) 36
cardiovascular diseases - prevention & control (34) 34
double-blind method (33) 33
health aspects (32) 32
myocardial-infarction (32) 32
treatment outcome (32) 32
epidemiology (31) 31
blood pressure (30) 30
myocardial infarction (30) 30
research (30) 30
cardiovascular diseases - mortality (29) 29
hypertension (29) 29
peripheral vascular disease (29) 29
stroke (29) 29
clinical medicine (28) 28
klinisk medicin (28) 28
coronary-heart-disease (26) 26
diabetes (26) 26
heart attacks (26) 26
medical and health sciences (26) 26
medicin och hälsovetenskap (26) 26
prognosis (26) 26
angiotensin-converting enzyme inhibitors - therapeutic use (25) 25
health risk assessment (25) 25
cardiovascular (24) 24
cholesterol (24) 24
coronary heart disease (24) 24
risk-factors (24) 24
canada (23) 23
cohort studies (22) 22
medical research (22) 22
analysis (21) 21
cardiovascular-disease (21) 21
care and treatment (21) 21
drug therapy (21) 21
risk assessment (21) 21
studies (21) 21
cardiovascular diseases - epidemiology (20) 20
clinical trials (20) 20
disease (20) 20
electrocardiography (20) 20
quebec - epidemiology (20) 20
blood-pressure (19) 19
cardiac and cardiovascular systems (19) 19
kardiologi (19) 19
metaanalysis (18) 18
ramipril - therapeutic use (18) 18
time factors (18) 18
men (17) 17
prevalence (17) 17
association (16) 16
atherosclerosis (16) 16
body mass index (16) 16
women (16) 16
cholesterol - blood (15) 15
incidence (15) 15
insulin (15) 15
myocardial ischemia - blood (15) 15
population (15) 15
proportional hazards models (15) 15
public, environmental & occupational health (15) 15
triglycerides - blood (15) 15
biomarkers - blood (14) 14
cardiology (14) 14
cholesterol, ldl - blood (14) 14
coronary-artery disease (14) 14
diabetes mellitus (14) 14
health (14) 14
heart diseases (14) 14
inflammation (14) 14
myocardial infarction - epidemiology (14) 14
ramipril (14) 14
angina (13) 13
cardiovascular diseases - drug therapy (13) 13
drug therapy, combination (13) 13
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (465) 465
French (46) 46
German (19) 19
Turkish (5) 5
Danish (4) 4
Estonian (4) 4
Slovenian (4) 4
Spanish (4) 4
Norwegian (3) 3
Portuguese (3) 3
Czech (2) 2
Greek (2) 2
Chinese (1) 1
Croatian (1) 1
Polish (1) 1
Russian (1) 1
Serbian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet (British edition), ISSN 0140-6736, 2016, Volume 388, Issue 10043, pp. 465 - 475
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2011, Volume 378, Issue 9798, pp. 1231 - 1243
Summary Background Although most cardiovascular disease occurs in low-income and middle-income countries, little is known about the use of effective secondary... 
Internal Medicine | STROKE | MEDICINE, GENERAL & INTERNAL | RISK-FACTORS | THERAPY | MYOCARDIAL-INFARCTION | AVAILABILITY | HEART-FAILURE | SELF-REPORT | ACUTE CORONARY SYNDROMES | MEDICINES | VALIDITY | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | Data Collection | Secondary Prevention | Stroke - drug therapy | Urban Population | Antihypertensive Agents - therapeutic use | Drug Utilization | Cardiovascular Agents - therapeutic use | Developed Countries | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Rural Population | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Coronary Disease - drug therapy | Adult | Female | Aged | Developing Countries | Platelet Aggregation Inhibitors - therapeutic use | Adrenergic beta-Antagonists - therapeutic use | Care and treatment | Research | Cardiovascular diseases | Health aspects | Cardiovascular agents | Studies | Low income groups | Stroke | Households | Socioeconomic factors | Data collection | Cardiovascular disease | Epidemiology | Economic development | Community | Drug use | Antihypertensive Agents/therapeutic use | Angiotensin-Converting Enzyme Inhibitors/therapeutic use | Cardiovascular Agents/therapeutic use | Coronary Disease/drug therapy | Cardiovascular Diseases/prevention & control | Platelet Aggregation Inhibitors/therapeutic use | Stroke/drug therapy | MEDICIN OCH HÄLSOVETENSKAP | Adrenergic beta-Antagonists/therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use | MEDICAL AND HEALTH SCIENCES
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2016, Volume 387, Issue 10013, pp. 61 - 69
Summary Background WHO has targeted that medicines to prevent recurrent cardiovascular disease be available in 80% of communities and used by 50% of eligible... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | Drug Costs | Platelet Aggregation Inhibitors - economics | Cardiovascular Diseases - drug therapy | Humans | Income | Malaysia | Secondary Prevention | Aspirin - supply & distribution | Urban Population | Angiotensin-Converting Enzyme Inhibitors - supply & distribution | Angiotensin-Converting Enzyme Inhibitors - economics | Sweden | Pakistan | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Iran | Rural Population | China | Adrenergic beta-Antagonists - economics | Brazil | Poland | Aspirin - therapeutic use | Aspirin - economics | Chile | Platelet Aggregation Inhibitors - therapeutic use | Adrenergic beta-Antagonists - therapeutic use | Cardiovascular Agents - economics | Colombia | Argentina | Platelet Aggregation Inhibitors - supply & distribution | Hydroxymethylglutaryl-CoA Reductase Inhibitors - supply & distribution | Hydroxymethylglutaryl-CoA Reductase Inhibitors - economics | United Arab Emirates | Adrenergic beta-Antagonists - supply & distribution | India | Pharmacies | Canada | Cardiovascular Agents - supply & distribution | Cardiovascular Agents - therapeutic use | Bangladesh | Family Characteristics | Developed Countries | Turkey | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | South Africa | Zimbabwe | Developing Countries | Drugs | Prevention | Usage | Cardiovascular diseases | Analysis | Disease prevention | Cardiovascular disease | Costs | Health care access | Preventive medicine | Health risk assessment | Klinisk medicin | Clinical Medicine
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2015, Volume 386, Issue 10007, pp. 1945 - 1954
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2016, Volume 374, Issue 21, pp. 2021 - 2031
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2014, Volume 371, Issue 7, pp. 612 - 623
Journal Article